PH

Peyman Hosseinchi

Associate at RA Ventures

Boston, Massachusetts

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $100,000.00

Work Experience

  • Associate

    2023

    NewCo creation with a focus on therapeutics Responsibilities include ideating new concepts, developing pipeline/corporate strategies, R&D planning, writing investment theses and operational execution

  • Associate

    2021 - 2023

    Working with the investment team to originate conviction in investment opportunities in public and private biotechs developing therapeutics; Advising RA's portfolio companies on their pipeline strategy

2016 - 2021

  • Postdoctoral Scholar

    2021 - 2021

  • Graduate Research Assistant

    2016 - 2021

    • Investigated the role of lymphatic vessels in regulating anti-tumor immunity in breast cancer • Contributed to development of various engineered immunotherapies in cancer and autoimmunity

2019 - 2020

  • Analyst Intern

    2019 - 2020

    Researched competitive companies and underlying markets in the food/peanut allergy space; advised on designing IND-enabling studies

2019 - 2019

  • Investment Analyst Intern

    2019 - 2019

  • Technology Venture Associate

    2018 - 2019

    Performed market and competitive analysis for early-stage startups; helped to raise $200K of seed funding for an oncology diagnostic startup

  • Biotechnology Analyst Intern

    2018 - 2018

    Performed due diligence on public biotechs (small/mid cap) to evaluate investment opportunities in immuno-oncology and rare diseases